Log in to save to my catalogue

Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of s...

Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2311922770

Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma

About this item

Full title

Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma

Publisher

Pakistan: Pakistan Journal of Pharmaceutical Sciences

Journal title

Pakistan journal of pharmaceutical sciences, 2019-07, Vol.32 (4(Supplementary)), p.1835-1842

Language

English

Formats

Publication information

Publisher

Pakistan: Pakistan Journal of Pharmaceutical Sciences

More information

Scope and Contents

Contents

A simple, specific, sensitive, robust, accurate and precise reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed and validated for simultaneous determination of sofosbuvir (SOF) and velpatasvir (VLP) in fixed dose combination tablets and plasma. Validation parameters, such as system suitability, accuracy, inter-day a...

Alternative Titles

Full title

Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2311922770

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2311922770

Other Identifiers

ISSN

1011-601X

How to access this item